China Pharma announces 1-for-10 reverse stock split
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 04 2025
0mins
Should l Buy CPHI?
Source: Business Insider
Reverse Stock Split Announcement: China Pharma Holdings plans to implement a 1-for-10 reverse stock split effective April 15, with trading on a split-adjusted basis starting that day under the symbol "CPHI" on NYSE American.
New CUSIP Number: Following the reverse stock split, the new CUSIP number for the common stock will be 16941T 401.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy CPHI?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on CPHI
About CPHI
China Pharma Holdings Inc is a company principally engaged in the development, manufacture, and marketing of pharmaceutical products for human use. The Company is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for high-incidence and high-mortality diseases and medical conditions prevalent in the PRC. The Company's products include dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The Company's products and solutions are mainly applied in the treatment of various diseases and medical conditions. The Company mainly operates in the domestic market.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.





